Boost Fertility

Coming – December 18

Improving Fertility For One-Tenth The Cost

Date and Time

December 18

–

12:00 PM ET / 9:00 AM PT

Details will be provided upon RSVP approval

About this Event

Each year millions of couples around the world struggle with conceiving a child. While some couples can afford the tens of thousands of dollars required to undergo IVF, most can’t.

Boost Fertility is on a mission to ensure that anyone who wants clinical-grade infertility treatment can get it by making it affordable and available for all. Based on the work of a world leading sperm motility expert, Boost has developed a patented purification device that optimizes a non-invasive fertility treatment called IUI that is one-tenth the cost of IVF.

IUI doesn’t require the couple to go to a specialized fertility clinic and go through a long, painful, and expensive process that involves two minor surgeries, multiple injections, and strong medication. Any qualified health care provider can perform Boost IUI in their office with no more than 30 minutes of work.

Register today to join our Fireside Chat with Boost Fertility co-founder and CEO, Daniel Wilson, to learn how their technology unlocks a global market estimated to be worth $49B by 2030.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.